Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,344 public trials 2,835 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, Not Recruiting

2nd or 3rd TKI-stop After 2 Years Nilotinib Pre-treatment in CML-patients

NCT02917720

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations
  • Universitätsklinikum Freiburg Freiburg im Breisgau, Baden-Wurttemberg, Germany
  • Universitätsmedizin Mannheim Mannheim, Baden-Wurttemberg, Germany
  • Klinikum rechts der Isar München, Bavaria, Germany
  • Medizinische Hochschule Hannover Hannover, North Rhine-Westphalia, Germany
View all 15 locations
View Trial Details
Active, Not Recruiting

A Study of CLN-619 (Anti-MICA/MICB Antibody) in Patients With Relapsed and Refractory Multiple Myeloma

NCT06381141

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Mt. Sinai New York, United States
View Trial Details
Active, Not Recruiting

Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia

NCT04258943

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Blast Crisis, Blastic Phase Chronic Myelogenous Leukemia, +20 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Kaiser Permanente Downey Medical Center Downey, California, United States
View all 59 locations
View Trial Details
Active, Not Recruiting

A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia

NCT01920737

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +2 more
Locations
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Weill Cornell Medical Center New York, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details

Related conditions